In order to be granted a Priority Review, the company seeking the review must show the FDA they have the capability to manufacture and commercialize the approved product. ELTP $$$
Is all of this why the stock only trades at .32. I own a ton and am not seeing any appreciation on my investment. Those that didn't sell at .97 lost a ton and I feel bad for them.
I agree with you 100%! SequestOx ADF will be approved...here is why I am confident of it. I am asking again for any solid rebuttal out there why the FDA would not approve SequestOx when it has already approved Embeda?
If the FDA has approved Pfizer's Embeda with an ADT labeling, then why wouldn't they approve Elite's SequestOx with similar Abuse Deterrent Technology?